ZURICH: Chemotherapy as a treatment for advanced melanoma could soon become obsolete, researchers said today, after patients taking an experimental immuno-oncology drug from Bristol-Myers Squibb Co had a much higher survival rate and had other favourable results.
To continue reading the rest of the article, click here